Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1995 1
2005 1
2006 2
2007 1
2008 1
2009 3
2010 1
2011 3
2013 2
2014 1
2016 1
2018 2
2019 3
2020 2
2021 4
2022 6
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Pituitary stalk interruption syndrome.
Voutetakis A. Voutetakis A. Handb Clin Neurol. 2021;181:9-27. doi: 10.1016/B978-0-12-820683-6.00002-6. Handb Clin Neurol. 2021. PMID: 34238482 Review.
Pituitary stalk interruption syndrome (PSIS) is a distinct developmental defect of the pituitary gland identified by magnetic resonance imaging and characterized by a thin, interrupted, attenuated or absent pituitary stalk, hypoplasia or aplasia of the …
Pituitary stalk interruption syndrome (PSIS) is a distinct developmental defect of the pituitary gland identifie …
Pituitary stalk interruption syndrome: phenotype, predictors, and pathophysiology of perinatal events.
Diwaker C, Thadani P, Memon SS, Sarathi V, Lila AR, Arya S, Krishnappa B, Karlekar M, Patil VA, Shah N, Bandgar T. Diwaker C, et al. Pituitary. 2022 Aug;25(4):645-652. doi: 10.1007/s11102-022-01243-x. Epub 2022 Jun 24. Pituitary. 2022. PMID: 35749012
PURPOSE: There is limited data regarding Pituitary Stalk Interruption Syndrome (PSIS) from India. Moreover, the pathophysiological link between perinatal events and PSIS is unclear. ...CONCLUSION: Later age at presentation and frequent hypogonadism wer …
PURPOSE: There is limited data regarding Pituitary Stalk Interruption Syndrome (PSIS) from India. Moreover, the …
Exome sequencing in 16 patients with pituitary stalk interruption syndrome: A monocentric study.
Brauner R, Bignon-Topalovic J, Bashamboo A, McElreavey K. Brauner R, et al. PLoS One. 2023 Dec 14;18(12):e0292664. doi: 10.1371/journal.pone.0292664. eCollection 2023. PLoS One. 2023. PMID: 38096238 Free PMC article.
Pituitary stalk interruption syndrome (PSIS) is a rare disorder characterized by an absent or ectopic posterior pituitary, absent or interrupted pituitary stalk and anterior pituitary hypoplasia on magnetic resonance imaging (MRI), as well in some case …
Pituitary stalk interruption syndrome (PSIS) is a rare disorder characterized by an absent or ectopic posterior …
Copy number variation in pituitary stalk interruption syndrome: A large case series of sporadic non-syndromic patients and literature review.
Correa-Silva SR, Kunii I, Mitne-Neto M, Moreira CM, Dias-da-Silva MR, Abucham J. Correa-Silva SR, et al. J Neuroendocrinol. 2023 Jan;35(1):e13221. doi: 10.1111/jne.13221. Epub 2022 Dec 10. J Neuroendocrinol. 2023. PMID: 36495109 Review.
Abnormal hypothalamic/posterior pituitary development appears to be a major determinant of pituitary stalk interruption syndrome (PSIS). The observation of familial cases and associated congenital abnormalities suggests a genetic basis. ...For t …
Abnormal hypothalamic/posterior pituitary development appears to be a major determinant of pituitary stalk interruption …
Bone Mineral Density in Pituitary Stalk Interruption Syndrome: The Role of Insulin-Like Growth Factor-1 and Testosterone at Different Skeletal Sites.
Zhu Y, Nie M, Wang X, Huang Q, Yu B, Zhang R, Zhang J, Sun B, Mao J, Wu X. Zhu Y, et al. Endocr Pract. 2022 Nov;28(11):1118-1124. doi: 10.1016/j.eprac.2022.07.011. Epub 2022 Aug 5. Endocr Pract. 2022. PMID: 35940470
OBJECTIVE: This study aimed to determine the clinical indicators influencing bone mineral density (BMD) of the lumbar spine and femoral neck in patients with pituitary stalk interruption syndrome (PSIS) who underwent multiple hormone replacement therap …
OBJECTIVE: This study aimed to determine the clinical indicators influencing bone mineral density (BMD) of the lumbar spine and femoral neck …
Relationship between growth hormone deficiency and nonalcoholic fatty liver disease in patients with pituitary stalk interruption syndrome.
Huang Q, Xu H, Wang X, Mao J, Yu B, Zhu Y, Zhang R, Sun B, Zhang J, Ji W, Ma W, Nie M, Wu X. Huang Q, et al. Clin Endocrinol (Oxf). 2022 Nov;97(5):612-621. doi: 10.1111/cen.14732. Epub 2022 Apr 17. Clin Endocrinol (Oxf). 2022. PMID: 35384023
BACKGROUND: Pituitary stalk interruption syndrome (PSIS), characterized by thinning or disappearance of the pituitary stalk, hypoplasia of the anterior pituitary, and an ectopic posterior pituitary, can lead to congenital combined pituitary hormone def …
BACKGROUND: Pituitary stalk interruption syndrome (PSIS), characterized by thinning or disappearance of the pitu …
The pituitary stalk interruption syndrome: endocrine features and benefits of growth hormone therapy.
El Chehadeh S, Bensignor C, de Monléon JV, Méjean N, Huet F. El Chehadeh S, et al. Ann Endocrinol (Paris). 2010 Mar;71(2):102-10. doi: 10.1016/j.ando.2009.11.007. Epub 2009 Dec 30. Ann Endocrinol (Paris). 2010. PMID: 20044069
INTRODUCTION: Childhood anterior-pituitary insufficiency has many causes (malformative, genetic, traumatic, tumoral...). One particular entity can be clearly identified: pituitary stalk interruption syndrome (PSIS). The aim of our study was to analyse …
INTRODUCTION: Childhood anterior-pituitary insufficiency has many causes (malformative, genetic, traumatic, tumoral...). One particular enti …
Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development.
Lodge EJ, Xekouki P, Silva TS, Kochi C, Longui CA, Faucz FR, Santambrogio A, Mills JL, Pankratz N, Lane J, Sosnowska D, Hodgson T, Patist AL, Francis-West P, Helmbacher F, Stratakis C, Andoniadou CL. Lodge EJ, et al. JCI Insight. 2020 Oct 27;5(23):e134310. doi: 10.1172/jci.insight.134310. JCI Insight. 2020. PMID: 33108146 Free PMC article.
The majority of cases are sporadic and of unknown cause. We screened 28 patients with pituitary stalk interruption syndrome (PSIS) for mutations in the FAT/DCHS family of protocadherins that have high functional redundancy. ...Overlapping infundibular …
The majority of cases are sporadic and of unknown cause. We screened 28 patients with pituitary stalk interruption s …
Pituitary stalk interruption syndrome and isolated pituitary hypoplasia may be caused by mutations in holoprosencephaly-related genes.
Tatsi C, Sertedaki A, Voutetakis A, Valavani E, Magiakou MA, Kanaka-Gantenbein C, Chrousos GP, Dacou-Voutetakis C. Tatsi C, et al. J Clin Endocrinol Metab. 2013 Apr;98(4):E779-84. doi: 10.1210/jc.2012-3982. Epub 2013 Mar 8. J Clin Endocrinol Metab. 2013. PMID: 23476075
In 10-15% of HPE patients, mutations in specific genes have been identified (eg, SHH, TGIF, SIX3). Pituitary stalk interruption syndrome (PSIS) constitutes a distinct abnormality of unknown pathogenesis, whereas isolated pituitary hypoplasia (IPH) has …
In 10-15% of HPE patients, mutations in specific genes have been identified (eg, SHH, TGIF, SIX3). Pituitary stalk interrup …
Efficacy of Pulsatile Gonadotropin-Releasing Hormone Therapy in Male Patients: Comparison between Pituitary Stalk Interruption Syndrome and Congenital Hypogonadotropic Hypogonadism.
Huang Q, Mao J, Wang X, Yu B, Ma W, Ji W, Zhu Y, Zhang R, Sun B, Zhang J, Nie M, Wu X. Huang Q, et al. Endocr Pract. 2022 May;28(5):521-527. doi: 10.1016/j.eprac.2022.02.008. Epub 2022 Feb 24. Endocr Pract. 2022. PMID: 35218954
OBJECTIVE: Pulsatile gonadotropin-releasing hormone (GnRH), widely used to induce spermatogenesis in congenital hypogonadotropic hypogonadism (CHH) patients, can restore the pituitary-testis axis function in men with pituitary stalk interruption syndrome …
OBJECTIVE: Pulsatile gonadotropin-releasing hormone (GnRH), widely used to induce spermatogenesis in congenital hypogonadotropic hypogonadis …
34 results